Related Experiment Video
Updated: Jun 2, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Pigment epithelial-derived factor inhibits c-FLIP expression and assists ciglitazone-induced apoptosis in
1Department of Ophthalmology, Chang Gang Memorial Hospital, Chia-Yi County, Taiwan, Republic of China.
Background:
Pigment epithelial-derived factor (PEDF) displays its antiangiogenicity by mechanisms partly involving suppression of the cellular FADD-like IL-1β-converting enzyme (FLICE)/caspase-8-inhibitory protein (c-FLIP) expression in endothelial cells. c-Jun NH(2)-terminal kinases (JNKs) regulate c-FLIP expression in endothelial cells. The effect of PEDF on other cells remains unclear.
Materials And Methods:
c-FLIP expression was assessed by semi-quantitative reverse transcriptase (RT)-PCR and immunoblotting. Pharmacological inhibitors were used to examine the involvement of PEDF signaling.
Results:
PEDF can also down-regulate c-FLIP expression in hepatoma cell line SK-Hep-1. PEDF induced p38 kinase phosphorylation in SK-Hep-1 cells. The effect of PEDF on c-FLIP expression was attenuated by p38 kinase inhibitor, but not JNK inhibitor. In addition, PEDF pretreatment significantly increased the sensitivity of SK-Hep-1 cells to procaspase-8 cleavage and apoptosis induced by ciglitazone.
Conclusion:
PEDF-induced p38 signaling causes c-FLIP down-regulation in SK-Hep-1. We postulate PEDF has a novel effect on apoptotic inducible activity in hepatoma cells.
Insights
Pigment epithelial-derived factor (PEDF) reduces cellular FLICE-inhibitory protein (c-FLIP) in hepatoma cells via p38 kinase signaling. This finding suggests PEDF enhances apoptotic activity in liver cancer cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Pigment epithelial-derived factor (PEDF) exhibits antiangiogenic properties partly by suppressing cellular FADD-like IL-1β-converting enzyme (FLICE)/caspase-8-inhibitory protein (c-FLIP) in endothelial cells.
- c-Jun NH(2)-terminal kinases (JNKs) are known regulators of c-FLIP expression in endothelial cells, but PEDF's effects on other cell types are not well understood.
Purpose of the Study:
- To investigate the effect of PEDF on c-FLIP expression in hepatoma cells.
- To elucidate the signaling pathways involved in PEDF-mediated c-FLIP regulation in hepatoma cells.
- To determine if PEDF influences the apoptotic response of hepatoma cells.
Main Methods:
- Semi-quantitative reverse transcriptase (RT)-PCR and immunoblotting were employed to assess c-FLIP expression.
- Pharmacological inhibitors targeting specific signaling pathways were utilized to examine PEDF signaling involvement.
- Hepatoma cell line SK-Hep-1 was used to study PEDF effects on c-FLIP and apoptosis.
Main Results:
- PEDF was found to down-regulate c-FLIP expression in SK-Hep-1 hepatoma cells.
- PEDF induced p38 kinase phosphorylation in SK-Hep-1 cells, and this effect on c-FLIP was abrogated by a p38 kinase inhibitor.
- PEDF pretreatment sensitized SK-Hep-1 cells to ciglitazone-induced procaspase-8 cleavage and apoptosis, an effect not mediated by JNK inhibition.
Conclusions:
- PEDF-induced p38 signaling is responsible for the down-regulation of c-FLIP in SK-Hep-1 cells.
- PEDF demonstrates a novel role in modulating apoptotic inducible activity within hepatoma cells.
- These findings suggest a potential therapeutic application of PEDF in liver cancer treatment by enhancing apoptosis.
Related Concept Videos
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway
Cell Specific Gene Expression
Dipeptidyl Peptidase 4 Inhibitors
The Intrinsic Apoptotic Pathway

